血液透析血管通路创新进展
本文综述了从动静脉内瘘、移植物、导管到生物工程血管和新型腔内技术创建内瘘的创新进展,指出通路狭窄、感染和血栓治疗仍不理想,强调个体化通路选择新范式和以患者为中心的护理。
要点
- 新型腔内技术创建动静脉内瘘可能解决及时获取内瘘的后勤问题。
- 通路护理正从聚焦动静脉内瘘转向个体化选择移植物和导管的互补新范式。
核心结论
- 血管通路领域正以循证热情聚焦血液透析的生存性问题,但法规和报销挑战持续存在。
- 患者选择和体验在终末期器官衰竭管理中常被忽视,应始终置于血管通路以患者为中心护理的核心。
研究设计与样本
- 本文为综述,回顾血液透析血管通路的历史创新与当前进展,未报告系统检索范围。
主要发现
- 自Scribner分流管后,动静脉内瘘是首个创新,随后出现动静脉移植物和导管。
- 上世纪已开发生物工程血管,近期人类血管创建技术使该领域焕发活力。
- 治疗通路狭窄、感染和血栓的方法仍不理想,创新技术正在演进。
- 新方法靶向血管通路的生物学和机械方面,如动静脉吻合的创建与成熟、流出道生物导管开发及中心静脉狭窄问题。
临床怎么用
- 血管通路护理应采纳新范式,在个体化通路放置算法中为动静脉移植物和透析导管提供互补定位。
- 临床应重视患者选择和体验,将其置于血管通路以患者为中心护理的核心。
- 多学科团队方法应继续推动血管通路领域的循证实践。
局限性
- 本文为综述,未报告系统检索策略、纳入标准或证据等级。
- 未提供具体研究数据、样本量或统计值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Worldwide, hemodialysis remains the prevalent dialysis modality for more than 2 million patients who require well-functioning vascular access for this procedure. Creation of an arteriovenous fistula for long-term hemodialysis was the first innovation since the Scribner shunt and was followed by the development of an arteriovenous graft and catheter. Bioengineered vessels were developed during the last century, but this field has been energized by recent technology relating to the creation of human vessels. Novel endovascular techniques for creating an arteriovenous fistula may resolve some of the logistical issues involved in obtaining a timely arteriovenous fistula. Treatment of access stenosis, infection, and thrombosis has remained suboptimal, and innovative technologies are evolving. Many new approaches are now targeting the biological and mechanical aspects of vascular access, such as creation and maturation of arterial and venous anastomoses, development of a biological conduit for outflow, and negotiating the problems of central vein stenosis. Importantly, processes of access care that have long focused on arteriovenous fistulas are now recognizing the new paradigm, providing a complementary niche to arteriovenous grafts and dialysis catheters in the algorithm for individualized access placement. Cumulatively, to the credit of the multidisciplinary team approach, the long overdue focus on the very existential issue of vascular access for hemodialysis is being approached with newfound evidence-based enthusiasm as the vexing challenges related to regulations and reimbursement in hemodialysis persist. Patient choice and experience, often missed and ignored in the challenging management of an end-stage organ failure, need to stay central as we focus on patient-centered care of vascular access.
引用
- Agarwal AK, Haddad NJ, Vachharajani TJ, et al. Innovations in vascular access for hemodialysis. Kidney Int. 2019. PMID: 30922666. doi:10.1016/j.kint.2018.11.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。